Medicine, Materials, Energy and Environment


Paul Schaffer

Dr. Paul Schaffer is the Associate Lab Director, Life Sciences Division at TRIUMF in Vancouver, BC. Before joining TRIUMF in 2009, Schaffer worked in the private sector as a Lead Scientist at General Electric Global Research in upstate New York where he was responsible for developing novel radiotracers for GE Healthcare. He graduated from the University of British Columbia in 1998 with a B.Sc. in both chemistry and biochemistry. He earned his Ph.D. at McMaster University in 2003, with his doctoral work focused on the design and synthesis of technetium and rhenium chelates as potential new radio-imaging or radiotherapy agents. Dr. Schaffer then became a Research Scientist at the McMaster Nuclear Reactor until joining the private sector. In response to the 2007-2009 technetium-99m radioisotope supply crises, Dr. Schaffer and his collaborators spearheaded one of four successful efforts to establish proof of concept commercial-scale production of technetium-99,. This effort saw four institutions come together with funding from Natural Resources Canada (NRCan) to demonstrate direct production of this isotope using Canada’s existing medical cyclotron infrastructure. For his leadership on the NRCan effort, Schaffer was recently recognized by Business in Vancouver as one of British Columbia’s Top Forty under 40 individuals. The NRCan-ITAP team was also recently awarded the 2015 NSERC Brockhouse Prize for Interdisciplinary Research. Dr. Schaffer continues to re-define the TRIUMF Life’s Sciences program by focusing on its core competencies to deliver specific outcomes, and continues to connect the TRIUMF program with industrial and commercial interests.